Hoth Therapeutics Inc (HOTH) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.04
• Market Cap: $16.45M
• EPS: $-1.02
• 52-Week High: $2.12
• 52-Week Low: $0.66

Market Sentiment

Hoth Therapeutics Inc currently has a Bullish sentiment score of 0.54.

About Hoth Therapeutics Inc

Hoth Therapeutics Inc. is a biopharmaceutical company based in New York that specializes in developing innovative therapies for dermatological conditions. With a pipeline that targets unmet medical needs, Hoth aims to provide advanced treatment options for patients suffering from skin diseases. The company's commitment to research and development, combined with a strategic approach to partnerships and collaborations, positions it to make significant contributions to the dermatology sector. As...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Hoth Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does HOTH pay dividends?

Hoth Therapeutics Inc (HOTH) does not currently pay a regular dividend.

What is HOTH's market cap?

Hoth Therapeutics Inc (HOTH) has a market capitalization of $16.45M with a current stock price of $1.04.